|
Volumn 97, Issue 2, 2001, Pages 442-448
|
Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEME;
IRON;
RECOMBINANT ERYTHROPOIETIN;
TRANSFERRIN RECEPTOR;
ANEMIA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL ACTIVITY;
CELL REGENERATION;
CONTROLLED STUDY;
DRUG EFFECT;
ERYTHROBLAST;
ERYTHROID CELL;
ERYTHROID PRECURSOR CELL;
HEMATOCRIT;
HEMATOPOIESIS;
INHIBITION KINETICS;
IRON OVERLOAD;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
REFRACTORY ANEMIA;
RETICULOCYTE;
|
EID: 0035863747
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood.V97.2.442 Document Type: Article |
Times cited : (31)
|
References (37)
|